- Home
- AQST vs IIIV Comparison
AQST vs IIIV Comparison
Compare AQST & IIIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- IIIV
- Stock Information
- Founded
- AQST 2004
- IIIV 2012
- Country
- AQST United States
- IIIV United States
- Employees
- AQST N/A
- IIIV N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- IIIV EDP Services
- Sector
- AQST Health Care
- IIIV Technology
- Exchange
- AQST Nasdaq
- IIIV Nasdaq
- Market Cap
- AQST 809.3M
- IIIV 720.4M
- IPO Year
- AQST 2018
- IIIV 2018
- Fundamental
- Price
- AQST $6.99
- IIIV $31.31
- Analyst Decision
- AQST Strong Buy
- IIIV Buy
- Analyst Count
- AQST 7
- IIIV 6
- Target Price
- AQST $10.71
- IIIV $34.33
- AVG Volume (30 Days)
- AQST 3.6M
- IIIV 135.4K
- Earning Date
- AQST 10-31-2025
- IIIV 11-17-2025
- Dividend Yield
- AQST N/A
- IIIV N/A
- EPS Growth
- AQST N/A
- IIIV N/A
- EPS
- AQST N/A
- IIIV 5.56
- Revenue
- AQST $44,132,000.00
- IIIV $248,271,000.00
- Revenue This Year
- AQST N/A
- IIIV N/A
- Revenue Next Year
- AQST $51.50
- IIIV $3.86
- P/E Ratio
- AQST N/A
- IIIV $5.57
- Revenue Growth
- AQST N/A
- IIIV 25.08
- 52 Week Low
- AQST $2.12
- IIIV $22.20
- 52 Week High
- AQST $7.55
- IIIV $33.59
- Technical
- Relative Strength Index (RSI)
- AQST 63.34
- IIIV 47.68
- Support Level
- AQST $6.78
- IIIV $31.55
- Resistance Level
- AQST $7.55
- IIIV $32.64
- Average True Range (ATR)
- AQST 0.41
- IIIV 1.01
- MACD
- AQST 0.04
- IIIV -0.09
- Stochastic Oscillator
- AQST 71.13
- IIIV 23.58
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About IIIV i3 Verticals Inc.
i3 Verticals Inc offers integrated payment and software solutions to small and medium-sized businesses and organizations in strategic vertical markets. Its operating segment includes Public Sector and Healthcare. The company generates maximum revenue from the Public Sector segment.